Home · Open Lab · Lot RGX-26-MELANOTAN-641
RGX-26-MELANOTAN-641Superseded
Melanotan-1 · 10 MG · Dermal Research · COA NS-2026-05194

Release test results

99.648%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 10.08 mg
Related impurities (total)0.352%
Endotoxin<1.0 EU/mg
HPLC retention time6.21 min
MethodHPLC + LC-MS
ResultPass · meets spec

Lot record

CompoundMelanotan-1
Presentation10 MG
Lot numberRGX-26-MELANOTAN-641
COA numberNS-2026-05194
Test date06 Sep 2026
Release date09 Sep 2026
Independent labNordicstar Labs
StatusSuperseded

Melanotan-1 — lot history

LotPresentationTestedHPLC purityStatus
RGX-26-MELANOTAN-105910 MGSep 8, 202699.699%Current
RGX-26-MELANOTAN-641 this lot10 MGSep 6, 202699.648%Superseded
RGX-26-MELANOTAN-74110 MGSep 4, 202699.610%Superseded
!
Research use only

This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →